The FY26 Melanoma Research Program Focused Program Award supports multidisciplinary research programs comprising 2-3 complementary projects focused on rare melanomas. Teams must include a rare melanoma survivor or patient advocate to guide research impact. The award requires a partnership of an Initiating PI and 1-2 Partnering PIs, each leading a project. Clinical trials are permitted. Pre-application by the Initiating PI is required to receive an invitation for full application submission.
Open to any type of entity, with no specific restrictions stated. Eligibility is unrestricted subject to additional clarifications.
